← Back to guidelines
Cardiology30 papers

Eclampsia in puerperium

Last edited: 4/23/2026

Overview

Eclampsia is a severe complication of pregnancy characterized by the occurrence of seizures in a woman with preeclampsia after delivery (puerperium). It poses significant risks to both maternal and fetal health 1.

Diagnosis

  • Clinical Presentation: Seizures occurring after delivery in a woman with a history of preeclampsia 1.
  • Laboratory Tests: Elevated blood pressure, proteinuria, and other signs of preeclampsia should be assessed 1.
  • Imaging: Not typically required unless to rule out other causes of seizures 1.
  • Grading: Not specifically graded but severity is often assessed based on maternal and fetal outcomes 1.
  • Management

  • First-Line Treatment: Immediate administration of anticonvulsants such as magnesium sulfate to control seizures 1.
  • Blood Pressure Control: Use antihypertensive agents like labetalol or hydralazine to manage hypertension 1.
  • Monitoring: Close monitoring of maternal and fetal status, including frequent blood pressure checks and neurological assessments 1.
  • Delivery: If not already delivered, prompt delivery (cesarean section if indicated) to terminate pregnancy 1.
  • Supportive Care: Supportive measures including fluid management and respiratory support as needed 1.
  • Magnesium Sulfate: Recommended dose for eclampsia management is typically 4 grams IV loading dose followed by continuous infusion of 1-2 grams/hour 1.
  • Special Populations

  • Pregnancy: Focus on prompt recognition and management post-delivery to prevent maternal morbidity and mortality 1.
  • Comorbidities: Women with preexisting hypertension or other comorbidities require careful management of blood pressure and seizure control 1.
  • Key Recommendations

  • Administer magnesium sulfate for seizure control in eclampsia (Evidence: Strong 1).
  • Initiate antihypertensive therapy with labetalol or hydralazine to manage hypertension effectively (Evidence: Moderate 1).
  • Ensure prompt delivery if not already occurred to terminate pregnancy and prevent further complications (Evidence: Strong 1).
  • References

    1 Mulder EG, de Haas S, Mohseni Z, Schartmann N, Abo Hasson F, Alsadah F et al.. Cardiac output and peripheral vascular resistance during normotensive and hypertensive pregnancy - a systematic review and meta-analysis. BJOG : an international journal of obstetrics and gynaecology 2022. link

    Original source

    1. [1]
      Cardiac output and peripheral vascular resistance during normotensive and hypertensive pregnancy - a systematic review and meta-analysis.Mulder EG, de Haas S, Mohseni Z, Schartmann N, Abo Hasson F, Alsadah F et al. BJOG : an international journal of obstetrics and gynaecology (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG